Finfeed

Discover small cap biotech stocks

We are a small team of investors building a high performing ASX small cap stock portfolio and sharing our investing journey with our readers for free.

Finfeed Portfolio
  • Next Investors Portfolio
  • Wise-Owl Portfolio
  • Catalyst Hunter Portfolio
  • Finfeed Portfolio
  • ──────────
  • Commodities
  • Energy Transition Metals
  • Lithium
  • Gold / Silver
  • Iron Ore
  • Nickel
  • Copper
  • Rare Earths
  • Helium
  • Biotech Research
  • Revenue Growth Stocks
  • Oil & Gas
  • Green Energy
  • Mining: Exploration Moonshot
  • Mining: JORC Definition
  • Mining: Feasibility Studies
  • Mining: Development
  • Past Investments
  • Tech: Pre-Revenue
  • Tech: Growth
  • Picks of the Year
  • Battery Materials

Finfeed if following on from one of Australia’s most successful biotech and life sciences fund managers to select and invest in early to mid-stage ASX listed biotechs.

Stocks Date of Initial Coverage Initial Entry Price Last Price Portfolio Weighting Shares Held Macro Theme Actively Sharing Highest Point Performance from Initial Entry
ALA 1645102800 18-Feb-2022 $0.038 $0.031
2.51%
13,631,579 Biotech 45% -18%
DXB 1629036000 16-Aug-2021 $0.200 $0.145
2.18%
2,525,000 Biotech 140% -28%
Stocks Date of Initial Coverage Initial Entry Price Last Price Portfolio Weighting Shares Held Macro Theme Actively Sharing Highest Point Performance from Initial Entry
ALA 1645102800 18-Feb-2022 $0.038 $0.031
2.51%
13,631,579 Biotech 45% -18%
DXB 1629036000 16-Aug-2021 $0.200 $0.145
2.18%
2,525,000 Biotech 140% -28%

Looking for a stock that has been removed from our Portfolio? Visit our “bottom drawer” portfolio and past investments page.

The past performance is not and should not be taken as an indication of future performance. Caution should be exercised in assessing past performance. This product, like all other financial products, is subject to market forces and unpredictable events that may adversely affect future performance.

What does Finfeed do?

We invest in around 10 carefully selected ASX small cap companies per year. We share our commentary as these companies execute on their business plan over time.

Why is Finfeed Free?

Companies we are invested in can pay us a fee to publicly share our commentary on how our investment is progressing.

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X